Cabot Corporation (CBT) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
CBT Revenue Growth
Revenue Breakdown (FY 2025)
CBT's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
CBT Revenue Analysis (2014–2025)
As of May 8, 2026, Cabot Corporation (CBT) generated trailing twelve-month (TTM) revenue of $3.58 billion, reflecting slight decline in growth of -3.4% year-over-year. The most recent quarter (Q2 2026) recorded $904.0 million in revenue, up 6.5% sequentially.
Looking at the longer-term picture, CBT's 5-year compound annual growth rate (CAGR) stands at +7.3%, indicating steady revenue expansion. The company achieved its highest annual revenue of $4.32 billion in 2022.
Revenue diversification analysis shows CBT's business is primarily driven by Reinforcement Materials (65%), and Performance Chemicals (35%). With over half of revenue concentrated in Reinforcement Materials, the company maintains significant focus in this area while developing other growth vectors.
When compared to Basic Materials sector peers including KRO (-1.0% YoY), IOSP (-3.7% YoY), and HWKN (+11.7% YoY), CBT has underperformed the peer group in terms of revenue growth. Compare CBT vs KRO →
CBT Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CBTCurrent | $3.6B | -3.4% | +7.3% | 16.7% | |
 KRO | $1.9B | -1.0% | +2.6% | -1.7% | |
 IOSP | $1.8B | -3.7% | +8.3% | 8.8% | |
 HWKN | $974M | +11.7% | +12.5% | 12.2% | |
 TROX | $2.9B | -3.9% | +1.0% | -0.7% | |
 ASIX | $1.5B | +0.3% | +5.6% | 4.4% |
CBT Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $3.71B | -7.0% | $940.0M | 25.3% | $621.0M | 16.7% |
| 2024 | $3.99B | +1.6% | $960.0M | 24.0% | $614.0M | 15.4% |
| 2023 | $3.93B | -9.0% | $839.0M | 21.3% | $526.0M | 13.4% |
| 2022 | $4.32B | +26.8% | $885.0M | 20.5% | $389.0M | 9.0% |
| 2021 | $3.41B | +30.4% | $799.0M | 23.4% | $454.0M | 13.3% |
| 2020 | $2.61B | -21.7% | $500.0M | 19.1% | $21.0M | 0.8% |
| 2019 | $3.34B | +2.9% | $685.0M | 20.5% | $306.0M | 9.2% |
| 2018 | $3.24B | +19.3% | $781.0M | 24.1% | $156.0M | 4.8% |
| 2017 | $2.72B | +12.7% | $652.0M | 24.0% | $336.0M | 12.4% |
| 2016 | $2.41B | -16.1% | $578.0M | 24.0% | $250.0M | 10.4% |
See CBT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CBT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CBT vs LIN
Side-by-side business, growth, and profitability comparison vs Linde plc.
Start ComparisonCBT — Frequently Asked Questions
Quick answers to the most common questions about buying CBT stock.
Is CBT's revenue growth accelerating or slowing?
CBT revenue growth slowed to -3.4%, below the 5-year CAGR of +7.3%. TTM revenue is $3.6B. The deceleration marks a shift from historical growth rates.
What is CBT's long-term revenue growth rate?
Cabot Corporation's 5-year revenue CAGR of +7.3% reflects the variable expansion pattern. Current YoY growth of -3.4% is near this long-term average.
How is CBT's revenue distributed by segment?
CBT reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.